Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Janakiraman

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Journal of Neuro-Oncology|October 27, 2001
Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: successful treatment with allogeneic bone marrow transplantL R Rogers, N Janakiraman, C Kasten-Sportes, et al.
Journal of the Mechanical Behavior of Biomedical Materials|July 26, 2011
Crack tip fracture toughness of base glasses for dental restoration glass-ceramics using crack opening displacementsJ Deubener, M Höland, W Höland, et al.
Archives of Internal Medicine|January 1, 1983
Smoldering acute granulocytic leukemia. Observations on its natural history and morphologic characteristicsE J Van Slyck, J W Rebuck, C C Waddell, et al.
Bone Marrow Transplantation|March 29, 2000
Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purgingS C Gautam, Y X Xu, M Dumaguin, et al.
Biochemical Pharmacology|November 14, 2001
Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine productionX Gao, Y X Xu, N Janakiraman, et al.
Clinical Immunology (Orlando, Fla.)|February 13, 2001
IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatmentY X Xu, X Gao, N Janakiraman, et al.
Cancer Gene Therapy|August 5, 2000
Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cellsS C Gautam, Y X Xu, M Dumaguin, et al.
Hematopathology and Molecular Hematology|January 1, 1997
Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cellsY X Xu, K R Pindolia, N Janakiraman, et al.
Biochemical Pharmacology|August 27, 1998
Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane)S C Gautam, Y X Xu, K R Pindolia, et al.
Hematology (Amsterdam, Netherlands)|July 15, 2016
IL1α and TNFα Induction of Monocyte Chemoattractant Protein-1 (MCP-1/JE) in Bone Marrow Stromal Cells: The Role of Protein Kinase C (PKC) and Protein Tyrosine Kinase (PTK) ActivityY Xian-Xu, K R Pindolia, N Janakiraman, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of Neuro-Oncology|October 27, 2001
Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: successful treatment with allogeneic bone marrow transplantL R Rogers, N Janakiraman, C Kasten-Sportes, et al.
Journal of the Mechanical Behavior of Biomedical Materials|July 26, 2011
Crack tip fracture toughness of base glasses for dental restoration glass-ceramics using crack opening displacementsJ Deubener, M Höland, W Höland, et al.
Archives of Internal Medicine|January 1, 1983
Smoldering acute granulocytic leukemia. Observations on its natural history and morphologic characteristicsE J Van Slyck, J W Rebuck, C C Waddell, et al.
Bone Marrow Transplantation|March 29, 2000
Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purgingS C Gautam, Y X Xu, M Dumaguin, et al.
Biochemical Pharmacology|November 14, 2001
Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine productionX Gao, Y X Xu, N Janakiraman, et al.
Clinical Immunology (Orlando, Fla.)|February 13, 2001
IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatmentY X Xu, X Gao, N Janakiraman, et al.
Cancer Gene Therapy|August 5, 2000
Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cellsS C Gautam, Y X Xu, M Dumaguin, et al.
Hematopathology and Molecular Hematology|January 1, 1997
Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cellsY X Xu, K R Pindolia, N Janakiraman, et al.
Biochemical Pharmacology|August 27, 1998
Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane)S C Gautam, Y X Xu, K R Pindolia, et al.
Hematology (Amsterdam, Netherlands)|July 15, 2016
IL1α and TNFα Induction of Monocyte Chemoattractant Protein-1 (MCP-1/JE) in Bone Marrow Stromal Cells: The Role of Protein Kinase C (PKC) and Protein Tyrosine Kinase (PTK) ActivityY Xian-Xu, K R Pindolia, N Janakiraman, et al.
Pageof 5